Skip to main content
. 2011 Jan;3(1):5–20. doi: 10.1002/emmm.201000105

Figure 9. Urinary Hsp72 levels as a biomarker of AKI in humans.

Figure 9

  • A, B. Hsp72 levels assessed by Western blot and ELISA, respectively, in five healthy kidney donors (▪) and nine patients that were diagnosed with AKI (▴).
  • C. Serum creatinine from five patients with no evidence of AKI (○) or in five patients with AKI diagnosed with AKIN criteria (•).
  • D. Urine output from five patients with no evidence of AKI (○) or in five patients with AKI diagnosed with AKIN criteria (•).
  • E. Daily urinary Hsp72 levels from patients with diagnosed AKI.
  • F. Daily urinary Hsp72 levels in patients without AKI.

The samples were collected during three days before and 5 days after AKI was diagnosed. *p < 0.05 versus 3 days before AKI.